Effects of perioperative iloprost on patency of femorodistal bypass grafts

European Journal of Vascular and Endovascular Surgery

Volumn 12, Issue 3, 1996, Pages 363-371

  Watson, H R ^a   Lorentzen, J E ^a   Schroeder, T V ^a   Nielson O M, ^a   Simms, M H ^a   Thomson, I A ^a   Garnham, A ^a   Baird, R N ^a   Lamont, P M ^a   Tennant, S G W ^a   Harris, P L ^a   Wolfe, J H N ^a   Taylor, R S ^a   Dormandy, J A ^a   Mcfarland, R J ^a   Lambert, D ^a   Redwood, N ^a   Horrocks, M ^a   Horrocks, E H ^a  

^a BAYER PHARMA AG   (Germany)

Author keywords

Clinical outcome; Controlled randomised trial; Femorodistal bypass; Iloprost; Patency

Indexed keywords

ANTICOAGULANT AGENT; ILOPROST;

ADULT; AGED; ARTICLE; BLOOD VESSEL PROSTHESIS; BYPASS SURGERY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; EUROPE; FEMALE; FLUSHING; FOLLOW UP; GRAFT PATENCY; HEADACHE; HUMAN; HYPOTENSION; INTRAVENOUS DRUG ADMINISTRATION; LEG AMPUTATION; LEG ISCHEMIA; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; NAUSEA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TIME; TREATMENT OUTCOME; VEIN GRAFT;

EID: 10344250936     PISSN: 10785884     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1078-5884(96)80258-9     Document Type: Article

References (0)